SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of Agilent Advanced Therapeutics, a unified Contract Development and Manufacturing Organization ...

Citi is positioning selectively across life sciences by favoring recovery names with clear catalysts while avoiding companies navigating accounting uncertainty, with Agilent’s pending Biocare deal ...

Agilent Technologies acquires Biocare Medical for $950M to expand into high-growth pathology and cancer diagnostics, enhancing recurring consumables revenue streams. Agilent trades below historical ...

March 9 (Reuters) - Life sciences firm Agilent Technologies (A.N), opens new tab said on Monday that it will acquire privately held clinical pathology firm Biocare Medical in an all-cash ‌deal valued ...

Agilent Technologies Inc. agreed to acquire privately held Biocare Medical, which makes instruments and materials used in cancer research, in an all-cash transaction valued at $950 million. Biocare ...

🛍️ Amazon Big Spring Sale: 100+ editor-approved deals worth buying right now 🛍️ By Justin Pot Published Feb 28, 2026 1:00 PM EST Add Popular Science (opens in a new tab) Adding us as a Preferred ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in 1993 in Alexandria, VA., by brothers David and Tom ...

As snow piles up across Michigan, SEMCO ENERGY Gas Company is urging customers to keep natural gas meters and appliance vents clear to avoid safety risks and potential service disruptions, according ...

SEBRING ‒ Residents might've noticed a new, $11 tech fee on their quarterly water bill for new meters they do not have. And, judging by posts on Facebook, they have. Village manager Tim Gabrelcik said ...

I can't stand opening the Microsoft Store. It's slow to load, confusing to browse, and full of ads for things I don't care about. Luckily, thanks to a new feature, I don't have to open the Microsoft ...

Sam Illingworth does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...